Step 1 of 2
Through this downloadable slideset, dive into the emerging role of CELMoDs in lymphoma with a focus on golcadomide in B-cell lymphomas, including diffuse large B-cell lymphoma and follicular lymphoma. Readers will explore the mechanism of action of CELMoDs, evolving clinical evidence across frontline and relapsed/refractory settings, combination strategies with chemoimmunotherapy and immune-directed therapies, and practical considerations for patient selection, treatment sequencing, and management of treatment-related adverse events.